Cargando…

Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis

BACKGROUND: To describe the incidence and the clinical characteristics of oligometastatic non-small cell lung cancer (NSCLC) patients. Oligometastatic NSCLC is gaining recognition as a clinical condition with a different prognosis compared to multi metastatic disease. Usually, four different scenari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gobbini, Elisa, Bertolaccini, Luca, Giaj-Levra, Niccolò, Menis, Jessica, Giaj-Levra, Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Oligometastatic NSCLC: Definition and Treatment Opportunities
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350077/ https://www.ncbi.nlm.nih.gov/pubmed/34430371 http://dx.doi.org/10.21037/tlcr-20-982

Ejemplares similares

Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review
por: Bertolaccini, Luca, et al.
Publicado: (2021)

Oligometastatic non-small cell lung cancer: from biology to clinical practice
por: Infante, Maurizio V., et al.
Publicado: (2021)

How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review
por: Remon, Jordi, et al.
Publicado: (2021)

A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done
por: Belluomini, Lorenzo, et al.
Publicado: (2021)

Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review
por: Cortinovis, Diego, et al.
Publicado: (2021)

Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
por: Sundahl, Nora, et al.
Publicado: (2021)

Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer
por: Rashdan, Sawsan, et al.
Publicado: (2021)

The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review
por: Berzenji, Lawek, et al.
Publicado: (2021)

Current and future research efforts in oligometastatic non-small cell lung cancer—a systematic review
por: Brandão, Mariana, et al.
Publicado: (2021)

Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review
por: Mentink, Jill F., et al.
Publicado: (2021)

Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies—a narrative review
por: Fallet, Vincent, et al.
Publicado: (2021)

Local ablative therapies in oligometastatic NSCLC-upfront or outback?—a narrative review
por: Tjong, Michael C., et al.
Publicado: (2021)

Local for advanced, is this a paradox?
por: Bungaro, Maristella, et al.
Publicado: (2021)

Alternative methods for local ablation—interventional pulmonology: a narrative review
por: Olive, Gerard, et al.
Publicado: (2021)

Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer
por: Pierret, Thomas, et al.
Publicado: (2020)

Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases
por: Pierret, Thomas, et al.
Publicado: (2022)

Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer
por: Gobbini, Elisa, et al.
Publicado: (2020)

Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized Medicine
por: Pinsolle, Julian, et al.
Publicado: (2019)

Repeated stereotactic radiosurgery for the treatment of relapsed brain metastases: is it time to give up whole-brain radiotherapy?
por: Nicosia, Luca, et al.
Publicado: (2020)

The Peninsula stage III non-small cell lung cancer audit: assessing the impact of COVID-19 on treatment decisions
por: Smith, Philippa, et al.
Publicado: (2023)

Activity of sotorasib against brain metastases from NSCLC harboring KRAS p.G12C mutation: a case report
por: Inno, Alessandro, et al.
Publicado: (2023)

Intra-fraction and Inter-fraction analysis of a dedicated immobilization device for intracranial radiation treatment
por: Ong, Chin Loon, et al.
Publicado: (2020)

Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system
por: Giaj-Levra, Niccolò, et al.
Publicado: (2019)

Stereotactic radiosurgery for the treatment of brainstem metastases: a multicenter retrospective study
por: Nicosia, Luca, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey
por: Tagliamento, Marco, et al.
Publicado: (2022)

Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia
por: Molon, Giulio, et al.
Publicado: (2022)

Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels(®): Toxicity and Efficacy Analysis on a Retrospective Series of 305 Patients
por: Nicosia, Luca, et al.
Publicado: (2022)

1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer
por: Nicosia, Luca, et al.
Publicado: (2022)

Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study)
por: Assié, Jean-Baptiste, et al.
Publicado: (2020)

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
por: Cui, W., et al.
Publicado: (2021)

179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center
por: Pierre, C., et al.
Publicado: (2021)

182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study
por: Marin, E., et al.
Publicado: (2021)

Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report
por: Pluchart, Hélène, et al.
Publicado: (2017)

Machine Learning–Based Analysis of Treatment Sequences Typology in Advanced Non–Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab
por: Chouaïd, Christos, et al.
Publicado: (2022)

1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment
por: Alongi, Filippo, et al.
Publicado: (2020)

PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer
por: Pastorello, Edoardo, et al.
Publicado: (2023)

The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature
por: Bruni, Alessio, et al.
Publicado: (2020)

A Natural Language Processing–Based Virtual Patient Simulator and Intelligent Tutoring System for the Clinical Diagnostic Process: Simulator Development and Case Study
por: Furlan, Raffaello, et al.
Publicado: (2021)

Learning Analytics Applied to Clinical Diagnostic Reasoning Using a Natural Language Processing–Based Virtual Patient Simulator: Case Study
por: Furlan, Raffaello, et al.
Publicado: (2022)

Factors associated with survival of patients with solid Cancer alive after intensive care unit discharge between 2005 and 2013
por: Gheerbrant, Hubert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_834p3l2dpqbempml58lcd02luj